Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mytrex Health TechnologiesROCO:4431 +2.06%64 Median PS Value is NT$55.00 as of Jul. 18, 2026, which is 100% below its 10-year median of 0.48. GuruFocus rates ROCO:4431 with a GF Score™ of 64/100 and a GF Value™ of NT$37.17 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,636 Industrial Products companies, Mytrex Health Technologies ranks better than 95.66% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Mytrex Health Technologies's Median PS Value or its related term are showing as below:
ROCO:4431'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31 Med: 0.48 Max: 0.73
Current: 0.32
During the past 13 years, the highest Price to Median PS Value of Mytrex Health Technologies was 0.73. The lowest was 0.31. And the median was 0.48.
ROCO:4431's Price-to-Median-PS-Value is ranked better than 95.66% of 1636
companies
in the Industrial Products industry
Industry Median: 1.09
vs ROCO:4431: 0.32
Mytrex Health Technologies (ROCO:4431) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Mytrex Health Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
17.35
/
55.00
=
0.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mytrex Health Technologies Median PS Value Related Terms
Mytrex Health Technologies Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4431 vs GEV, ETN, PH: Median PS Value Comparison
For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mytrex Health Technologies Price-to-Median-PS-Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Mytrex Health Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.0333.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mytrex Health Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$53.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mytrex Health Technologies (ROCO:4431) has a Median PS Value of NT$55.00 as of Jul. 18, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Mytrex Health Technologies and its competitors. This is 11358% above median its historical median of 0.48. Over the past decade, Mytrex Health Technologies' Median PS Value has ranged from 0.31 to 0.73. According to the industry distribution chart, Mytrex Health Technologies ranks #71 out of 1636 companies in the Industrial Products industry, placing it in the top 4.3%.
Is Mytrex Health Technologies' Median PS Value too high?
Mytrex Health Technologies' current Median PS Value of NT$55.00 is 11358% above median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 0.73. Based on the distribution chart, Mytrex Health Technologies ranks #71 out of 1636 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Mytrex Health Technologies has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' Median PS Value compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Mytrex Health Technologies ranks #71 out of 1636 companies for Median PS Value. This places Mytrex Health Technologies in the top 4% of its industry — outperforming the majority of peers. The industry median Median PS Value is 1.09. Historically, Mytrex Health Technologies' own Median PS Value has ranged from 0.31 to 0.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for an Industrial Products company?
The median Median PS Value among Industrial Products companies is 1.09, based on 1,636 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Mytrex Health Technologies and its competitors. For the Industrial Products industry, the median Median PS Value is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mytrex Health Technologies's current Median PS Value is NT$55.00, which is 11358% above median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$37.17, compared to a current price of NT$17.35 — trading 53.3% below its estimated fair value. The current Median PS Value is NT$55.00, which is 11358% above median its 10-year median of 0.48. Mytrex Health Technologies' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current Median PS Value is NT$55.00 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?
Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued.
The current stock price of NT$17.35 is trading 53.3% below its estimated GF Value™ of NT$37.17.
GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4431:
Median PS Value: NT$55.00 (11358% above median its 10-year median of 0.48)
GF Value™: NT$37.17 vs. price of NT$17.35 (53.3% below fair value)
No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
64GF Score
Get the complete analysis for ROCO:4431
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4431 has been successfully added to your 
